Mexico has become a testing ground for psychedelic therapies
From ibogaine to LSD, the benefits of psychedelics are not yet backed up by strong medical evidence
Olivia has suffered with depression and struggled to form romantic attachments ever since she was sexually assaulted. Counselling and medication scarcely helped. So in September 2023 she flew to Mexico and joined a retreat that uses 5-MeO-DMT, a psychedelic compound, as a therapeutic agent. She was “terrified”, but says the drug was “an opening” and that it let her body “feel what it needed to feel to start processing” her assault. She plans to return to Mexico for more psychedelic therapy this year.
Explore more
This article appeared in the The Americas section of the print edition under the headline “A different kind of help”
From the July 6th 2024 edition
Discover stories from this section and more in the list of contents
Explore the editionDiscover more
Entrevista con Javier Milei, presidente de Argentina
Transcripción de su encuentro con nuestro corresponsal
An interview with Javier Milei, Argentina’s president
A transcript of his meeting with our journalist
Mexico and Canada brace for Donald Trump’s tariff thrashing
Mexico’s Claudia Sheinbaum and Canada’s Justin Trudeau are taking different approaches to looming trade war
Javier Milei, free-market revolutionary
Argentina’s president explains how he has overturned the old economic order
Is Uruguay too stable for its own good?
The new president must deal with serious problems with growth, education and crime
Bolsonaro’s bid to regain Brazil’s presidency may end in prison
Brazilian police have accused some of his backers of involvement not just in a coup, but in an assassination plot